New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.

Related Keywords

Wuhan ,Hubei ,China ,Syria ,Syrian ,Andrii Vodolazhskyi Shutterstock , ,Ebiomedicine Journal ,Antibody ,Antibody Discovery ,Cars ,Ars Cov 2 ,Antibodies ,Artificial Intelligence ,Essay ,Coronavirus ,Covid 19 ,Efficacy ,Electron ,Electron Microscopy ,N Vivo ,Icroscopy ,Utation ,Pandemic ,Protein ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Virus ,